Cravath, Swaine & Moore LLP
David Greenwald is a partner in Cravath, Swaine & Moore LLP's litigation department. His areas of focus are patent litigation (particularly concerning pharmaceutical and biotechnological patents) and white collar criminal defense. Mr. Greenwald is a patent attorney registered with the U.S. Patent and Trademark Office.
Mr. Greenwald's representative life sciences matters have included:
- Representation in patent litigation under the BPCIA of the first biological drug company to obtain approval to market a biosimilar of Humira®, the world's largest-selling drug;
- Representation at trial of a major pharmaceutical company in Hatch-Waxman Act actions to enjoin approval of generic versions of posaconazole, a drug indicated for prevention of life-threatening fungal infections;
- Representation at trial of a major biological drug company in a patent infringement action involving patents covering PCSK9 inhibitors, therapeutic antibodies indicated for the reduction of LDL-cholesterol;
- Representation at trial of a pharmaceutical company in a Hatch-Waxman action to enforce patents covering formulations of formoterol, a drug indicated for the treatment of chronic obstructive pulmonary disease;
- Representation of a biopharmaceutical company in a patent licensing dispute with a medical research center, involving rights to CAR-T cancer therapy technology;
- Representation of a pharmaceutical company in an appeal from an adverse judgment enjoining generic entry of efavirenz, a drug indicated for the treatment of AIDS.
Mr. Greenwald received a bachelor's degree, summa cum laude, in biochemical sciences from Harvard College in 1990 and a J.D., with high honors, from the University of Chicago in 1993. Mr. Greenwald clerked for Hon. Richard A. Posner, Chief Judge, United States Court of Appeals for the Seventh Circuit.
Mr. Greenwald served as an Assistant United States Attorney for the Southern District of New York, Criminal Division between 1997 and 2000.